|
Year of Diagnosis |
Total | In Situ | Localized | Regional | Distant | Unknown | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Number | Percent | Number | Percent | Number | Percent | Number | Percent | Number | Percent | ||
| 2016-2020 | 513 | - | - | 388 | 75.6 | 72 | 14.0 | 31 | 6.0 | 22 | 4.3 |
| 2015-2019 | 484 | - | - | 361 | 74.6 | 69 | 14.3 | 30 | 6.2 | 24 | 5.0 |
| 2014-2018 | 440 | - | - | 319 | 72.5 | 61 | 13.9 | 28 | 6.4 | 32 | 7.3 |
| 2013-2017 | 396 | - | - | 287 | 72.5 | 56 | 14.1 | 22 | 5.6 | 31 | 7.8 |
| 2012-2016 | 361 | - | - | 257 | 71.2 | 51 | 14.1 | 24 | 6.6 | 29 | 8.0 |
| 2011-2015 | 388 | - | - | 294 | 75.8 | 48 | 12.4 | 23 | 5.9 | 23 | 5.9 |
| 2010-2014 | 423 | - | - | 325 | 76.8 | 53 | 12.5 | 24 | 5.7 | 21 | 5.0 |
| 2009-2013 | 445 | - | - | 349 | 78.4 | 60 | 13.5 | 23 | 5.2 | 13 | 2.9 |
| 2008-2012 | 466 | - | - | 366 | 78.5 | 63 | 13.5 | 25 | 5.4 | 12 | 2.6 |
| 2007-2011 | 500 | - | - | 406 | 81.2 | 56 | 11.2 | 21 | 4.2 | 17 | 3.4 |
| 2006-2010 | 433 | 1 | 0.2 | 345 | 79.7 | 46 | 10.6 | 18 | 4.2 | 23 | 5.3 |
| 2005-2009 | 397 | 1 | 0.3 | 310 | 78.1 | 36 | 9.1 | 16 | 4.0 | 34 | 8.6 |
| 2004-2008 | 419 | 1 | 0.2 | 329 | 78.5 | 30 | 7.2 | 18 | 4.3 | 41 | 9.8 |
| 2003-2007 | 406 | 1 | 0.2 | 323 | 79.6 | 21 | 5.2 | 16 | 3.9 | 45 | 11.1 |
| 2002-2006 | 388 | 1 | 0.3 | 306 | 78.9 | 21 | 5.4 | 16 | 4.1 | 44 | 11.3 |
| 2001-2005 | 442 | - | - | 359 | 81.2 | 23 | 5.2 | 16 | 3.6 | 44 | 10.0 |
| 2000-2004 | 503 | - | - | 422 | 83.9 | 28 | 5.6 | 17 | 3.4 | 36 | 7.2 |
| 1999-2003 | 531 | - | - | 441 | 83.1 | 31 | 5.8 | 17 | 3.2 | 42 | 7.9 |
| 1998-2002 | 533 | 1 | 0.2 | 440 | 82.6 | 37 | 6.9 | 15 | 2.8 | 40 | 7.5 |
| 1997-2001 | 530 | 1 | 0.2 | 431 | 81.3 | 40 | 7.5 | 15 | 2.8 | 43 | 8.1 |
| 1996-2000 | 486 | 1 | 0.2 | 381 | 78.4 | 41 | 8.4 | 14 | 2.9 | 49 | 10.1 |
| 1995-1999 | 417 | 2 | 0.5 | 306 | 73.4 | 39 | 9.4 | 16 | 3.8 | 54 | 12.9 |
| 1994-1998 | 350 | 2 | 0.6 | 246 | 70.3 | 32 | 9.1 | 21 | 6.0 | 49 | 14.0 |
| 1993-1997 | 335 | 4 | 1.2 | 220 | 65.7 | 32 | 9.6 | 25 | 7.5 | 54 | 16.1 |
| 1992-1996 | 349 | 4 | 1.1 | 188 | 53.9 | 29 | 8.3 | 26 | 7.4 | 102 | 29.2 |
| 1991-1995 | 330 | 4 | 1.2 | 168 | 50.9 | 29 | 8.8 | 30 | 9.1 | 99 | 30.0 |
| 1990-1994 | 307 | 3 | 1.0 | 152 | 49.5 | 27 | 8.8 | 28 | 9.1 | 97 | 31.6 |
| 1989-1993 | 284 | 3 | 1.1 | 131 | 46.1 | 31 | 10.9 | 20 | 7.0 | 99 | 34.9 |
| 1988-1992 | 247 | - | - | 99 | 40.1 | 28 | 11.3 | 16 | 6.5 | 104 | 42.1 |
| 1987-1991 | 166 | - | - | 72 | 43.4 | 23 | 13.9 | 16 | 9.6 | 55 | 33.1 |
| 1986-1990 | 140 | - | - | 47 | 33.6 | 17 | 12.1 | 12 | 8.6 | 64 | 45.7 |
| 1985-1989 | 121 | - | - | 31 | 25.6 | 12 | 9.9 | 8 | 6.6 | 70 | 57.9 |
| Notes: |
|---|
|
In Situ Stage represents the presence of malignant cells within the cell group from which they arose, with no penetration of basement membrane of the tissue and no stromal invasion. |
| Localized Stage represents invasive cancer confined to the organ of origin or intralumenal extension where specified as an intralumenal extension to immediately contiguous segments of the large bowel. |
| Regional Stage represents direct extension to adjacent organs or tissues or involvement of the regional lymph nodes. |
| Distant Stage represents direct continuity to non-adjacent organs, discontinuous metastasis or involvement of the distant lymph nodes. |
| COVID-19 Pandemic: In 2020, the highly publicized impact of the COVID-19 pandemic on health services and the consequential delays and reductions in cancer screening and diagnosis led to a decline in the 2020 incidence rates for most cancer sites. Because 2020 was a temporary, anomalous year, it can bias estimates such as cancer incidence trends. |
| Source : Michigan Resident Cancer Incidence File. Updated with cases processed through November 30, 2022. Division for Vital Records & Health Statistics, Michigan Department of Health & Human Services. |
|
Last Updated : April 13, 2023 |